C. Faust et al., THE ENZYMATIC DOMAIN OF CLOSTRIDIUM-DIFFICILE TOXIN-A IS LOCATED WITHIN ITS N-TERMINAL REGION, Biochemical and biophysical research communications (Print), 251(1), 1998, pp. 100-105
Clostridium difficile, an anaerobic pathogen encountered in human ente
ric disease, produces two major virulence factors, toxins A and B, whi
ch are members of a clostridial family of large cytotoxins. These are
glucosyltransferases, which use a UDP-sugar as co-substrate to glucosy
late and inactivate small GTPases of the Rho or Ras families, culminat
ing in cytotoxicity. Clinically, toxin A is perhaps the most important
family member, because it causes major tissue damage in the course of
disease, leading to a potentially lethal, pseudomembranous colitis. T
he location of the enzymatic domain of toxin A and mechanistic details
of its action are not yet known, so we wished to localize this domain
using gene deletion constructions from the full-length gene and by mo
nitoring glucosylation activity of encoded protein products. Toxin A d
eletions were obtained by successively truncating the C-terminal codin
g region. These were transformed into E. coil, cell lysates were prepa
red and they were assayed for their ability to glucosylate Rho A prote
in, using an in vitro enzymatic assay. We report that the UDP-glucose
binding site, the catalytic site for glucose transfer and the Rho A in
teraction site occur within the first 659 N-terminal amino acids of to
xin A, i.e., less than 25% of the length of holotoxin A. Localization
of the enzymatic domain of toxin A to these 659 N-terminal amino acids
should greatly simplify studies on mechanistic details of this clinic
ally important toxin. (C) 1998 Academic Press.